EverQuote EVER Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $178.49M+42.8% | $171.38M+67.8% | $145.77M+76.0% | $148.19M+143% | $124.97M+157% | ||
| $71.78M+16.1% | $75.15M+22.5% | $68.18M+41.3% | $54.96M+14.4% | $61.8M+61.4% | ||
| $257.07M+32.3% | $256.29M+49.2% | $223.96M+60.1% | $209.47M+79.0% | $194.34M+103% | ||
| $8.55M+31.6% | $7.88M+27.6% | $7.62M+18.9% | $7.17M+15.1% | $6.5M+12.9% | ||
| $21.5M0.0% | $21.5M0.0% | $21.5M0.0% | $21.5M0.0% | $21.5M0.0% | ||
| $323.97M+39.6% | $326.91M+55.3% | $256.05M+41.8% | $241.42M+52.8% | $232.15M+71.4% | ||
| $68.22M+19.1% | $76.85M+28.1% | $67.95M+44.6% | $58.99M+40.4% | $57.29M+73.2% | ||
| $1.77M-15.6% | $1.66M-5.8% | $1.39M-21.9% | $1.65M-13.3% | $2.1M+12.3% | ||
| $81.86M+1.8% | $87.22M+20.1% | $79.49M+32.5% | $69.19M+25.9% | $80.41M+70.9% | ||
| $83.11M+0.6% | $88.87M+18.2% | $81.12M+29.1% | $71.15M+24.6% | $82.65M+75.5% | ||
| -$63.2M+63.5% | -$81.87M+54.8% | -$139.62M+27.8% | -$158.49M+22.7% | -$173.19M+18.1% | ||
| $240.87M+61.1% | $238.04M+75.8% | $174.93M+48.6% | $170.27M+68.9% | $149.5M+69.3% | ||
| $323.97M+39.6% | $326.91M+55.3% | $256.05M+41.8% | $241.42M+52.8% | $232.15M+71.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are EverQuote's total assets?
- EverQuote (EVER) holds $324.0M in total assets, up 39.6% year over year.
- How much debt does EverQuote have?
- EverQuote carries $2.3M in total debt against $240.9M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does EverQuote have?
- EverQuote holds $178.5M in cash and equivalents.
- Can EverQuote cover its short-term obligations?
- Its current ratio is 3.14 — current assets exceed current liabilities.
- Where does EverQuote's balance sheet data come from?
- Every line is extracted from EverQuote's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
